NAT10-dependent N<sup>4</sup>-acetylcytidine modification mediates PAN RNA stability, KSHV reactivation, and IFI16-related inflammasome activation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37816771.
- Also identified by DOI 10.1038/s41467-023-42135-3 and PMC identifier 10564894.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
N-acetyltransferase 10 (NAT10) is an N<sup>4</sup>-acetylcytidine (ac<sup>4</sup>C) writer that catalyzes RNA acetylation at cytidine N<sup>4</sup> position on tRNAs, rRNAs and mRNAs. Recently, NAT10 and the associated ac<sup>4</sup>C have been reported to increase the stability of HIV-1 transcripts. Here, we show that NAT10 catalyzes ac<sup>4</sup>C addition to the polyadenylated nuclear RNA (PAN), a long non-coding RNA encoded by the oncogenic DNA virus Kaposi's sarcoma-associated herpesvirus (KSHV), triggering viral lytic reactivation from latency. Mutagenesis of ac<sup>4</sup>C sites in PAN RNA in the context of KSHV infection abolishes PAN ac<sup>4</sup>C modifications, downregulates the expression of viral lytic genes and reduces virion production. NAT10 knockdown or mutagenesis erases ac<sup>4</sup>C modifications of PAN RNA and increases its instability, and prevents KSHV reactivation. Furthermore, PAN ac<sup>4</sup>C modification promotes NAT10 recruitment of IFN-γ-inducible protein-16 (IFI16) mRNA, resulting in its ac<sup>4</sup>C acetylation, mRNA stability and translation, and eventual inflammasome activation. These results reveal a novel mechanism of viral and host ac<sup>4</sup>C modifications and the associated complexes as a critical switch of KSHV replication and antiviral immunity.
Medical subject headings
- Herpesvirus 8, Human